Next Generation News and Research

RSS

Malaria Infection Causes Permanent Damage to Resident Splenic CD163 Macrophages

Macrophages formed in the bone marrow can only assume the function of embryonal phagocytes, or "scavenger cells," to a certain degree according to a study by the University of Bonn and the Peter Doherty Institute for Infection and Immunity at the University of Melbourne.

5 Aug 2026

New Analytical Framework Captures Coordinated Host and Microbial Disease Responses

The trillions of microorganisms living in our intestine influence our health, from digestion and metabolism to immunity.

5 Aug 2026

Natural Product Derivatives Show High Potency Against Drug-Resistant Malaria Strains

Parasites are becoming highly resistant to existing drugs, and hence scientists at the University of California, Riverside are developing new drugs for the two major parasitic infectious diseases—babesiosis and malaria.

3 Aug 2026

T Cells Identify Dangerous Pathogenic Threats to Keep Bodies Healthy

Your body depends on T cells to stay healthy. These white blood cells act like a neighborhood watch in the body, helping the immune system spot threats such as viruses, bacteria, and cancer cells.

3 Aug 2026

Genetic Breakthrough Allows Early Prediction of Avocado Tree Flower Trait

Scientists have found a genetic switch that could shave years off avocado breeding by allowing researchers to identify one of a young tree's most important traits long before it flowers.

29 Jul 2026

arcoris bio and Europa Biosite Partner to Bring immunoMUSE® Kits to Europe and North American Market

arcoris bio, a Swiss life science research tools and in vitro diagnostics company, today announced a distribution partnership with Europa Biosite, a leading distributor of life science research products and services.

From arcoris bio AG 21 Jul 2026

UC San Diego and Innovative Genomics Institute Partner to Develop Cutting-Edge Genomic Tools

The University of California San Diego and the Innovative Genomics Institute (IGI), founded by Nobel laureate and CRISPR gene editing co-discoverer Jennifer Doudna, announced a new partnership today to jointly develop cutting-edge genomic tools for addressing large-scale challenges in health and the environment.

21 Jul 2026

University Launches Worldwide Search for Nature-Focused Researchers

An international search for researchers with a focus on nature-based solutions to improve business, the environment and the economy is underway.

15 Jul 2026

First Atomic Level Images Reveal Blueprint for Better RNA Drugs

RNA interference is a natural mechanism for living cells to control whether specific genes are being used or not.

30 Jun 2026

Mayo Clinic Scientists Discover Molecular Structures of Key Protein

After nearly four decades of research, Mayo Clinic scientists have revealed the molecular structures of protein kinase C beta (PKCβ), a key protein linked to cancer and neurological diseases.

29 Jun 2026

Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets

Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Bio-Techne Corporation, a Minneapolis-based global provider of life science tools, analytical technologies, and consumables, today entered into a definitive agreement pursuant to which Merck KGaA, Darmstadt, Germany, will, subject to customary closing conditions, acquire Bio-Techne for US$73 per share in cash, representing a total enterprise value of approximately US$11.3 billion (EUR 9.9 billion), a 36% premium to Bio-Techne's one-month volume weighted average trading price.

From Bio-Techne 26 Jun 2026

Scripps Research Identifies Erucamide Molecule as Shield Against Blindness

Many conditions that cause vision loss share a common feature: the gradual breakdown of the retina, the light-sensing tissue at the back of the eye.

23 Jun 2026

DNA Barcode Technology Enables Massive Simultaneous Drug Candidate Validation

A Korean research team has launched a public drug discovery service capable of screening and validating tens of millions of compounds simultaneously.

10 Jun 2026

Scientists Uncover How Marine Invertebrates Bypass Mammalian Epigenetic Rules

Typically, the information encoded in DNA allows organisms to develop, function and pass traits across generations.

3 Jun 2026

Introducing Evosep Proteomics to Standardize and Scale Proteomics for Research and Drug Development

Evosep announces the launch of Evosep Proteomics, an ecosystem designed to standardize and scale LC-MS-based proteomics for research and pharmaceutical drug development.

From Evosep 2 Jun 2026

A New Non-Destructive Tool Maps Active Transcription Profiles in Living Tissue

Cell function is determined by how DNA is expressed into proteins. That process includes two main steps - transcription, when messenger RNA (mRNA) makes copies of active genes, and translation, when mRNA guides protein assembly.

2 Jun 2026

ION Secures First Global Partners, Advancing Australia's Next Generation of Life Sciences Innovation

Sydney's life sciences sector has reached a major milestone, with Kurraba Group announcing the first confirmed partners for ION – a purpose-built commercial life sciences precinct set to redefine innovation infrastructure in Australia.

From ION 25 May 2026

Synthetic Biology and Artificial Intelligence Transform the Discovery of Mysterious Orphan Receptors

A new review highlights how synthetic biology, AI, and spatial omics could transform ligand-receptor discovery from one-by-one searches into network-level mapping

23 May 2026

Scientists Discover How DNA Damage Modulates the Tumor Microenvironment for Therapy

Researchers have identified a pathway that triggers an immune response in cells with defective DNA repair.

14 May 2026

How the Microbiome Shapes Cancer Immunity and Therapy Response

This review examines how the human microbiome regulates anti-tumor immunity through DNA damage, inflammation, immune-cell activity, microbial metabolites, and tumor microenvironment remodeling. It highlights emerging microbiome-based strategies, including FMT, probiotics, prebiotics, engineered bacteria, and live biotherapeutics, while stressing the need for rigorous validation and clinical trials.

29 Apr 2026